Development of new targeted therapies for breast cancer.

Cancer treatment and research

Volumn 141, Issue , 2008, Pages 119-134

  Doyle, Danielle M ^a   Miller, Kathy D ^a  

^a Indiana Cancer Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE; TRASTUZUMAB;

BREAST TUMOR; DRUG ANTAGONISM; FEMALE; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 40949146624     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-0-387-73161-2_8     Document Type: Review

References (59)